![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. | ![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | |
Founding Date | Founding Date 1849 | Founding Date 1923 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Watertown, US HQ Cambridge, US |
Employees | Employees 81,0008% decrease | Employees 14,754 | Employees 207 |
Valuation ($) | Valuation ($) 163.9 b | Valuation ($) 20.8 b | Valuation ($) 3.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) | Revenue (est.) $39.2m (FY, 2025) |
Cost of goods | Cost of goods $16.1b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) | Cost of goods $39.2m (FY, 2025) |
Gross profit | Gross profit $46.5b (FY, 2025) | Gross profit ¥2t (FY, 2026) | Gross profit N/A |
Net income | Net income $7.8b (FY, 2025) | Net income ¥291.6b (FY, 2026) | Net income ($311.4m) (FY, 2025) |

Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View company
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company